<DOC>
	<DOCNO>NCT00566462</DOCNO>
	<brief_summary>This two-arm , double-blind , placebo-controlled study .</brief_summary>
	<brief_title>Assessment Perampanel ( E2007 ) Synaptic Dopamine Mild-moderate PD Patients : A Pilot Study With ^123I-IBZM SPECT</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Male female patient idiopathic PD fulfilling United Kingdom Parkinson 's Disease Society Brain Bank ( UKPDSBB ) diagnostic criterion , good response levodopa . The requirement UKPDSBB Step 2 prior brain imaging discretion investigator . Clinical diagnosis idiopathic Parkinson 's disease ( patient must least two three cardinal symptom : rest tremor , rigidity , bradykinesia ) Hoehn Yahr Stage II IV . Treatment monotherapy levodopa plus aromatic acid decarboxylase inhibitor ( carbidopa ) . The carbidopa/levodopa medication take least two time daily ( exclude bedtime/night time dose ) maximum eight dos daily ( include bedtime/night time dose ) . Intermittent use either liquid form levodopa subcutaneous apomorphine permit . Age &gt; 30 year age Women incapable bearing child ( e.g. , clinically assess infertile , include surgically sterile ) practice effective contraception ( e.g. , abstinence , intrauterine device barrier method plus hormonal method ) . Postmenopausal woman may recruit must amenorrheic least 1 year consider . Women must negative serum betahuman chorionic gondotrophin ( βHCG ) test Screening Visit negative urine pregnancy test prior radiotracer administration day SPECT scan session . Women must also willing remain current form contraception duration study . 2 . In investigator 's opinion , patient able complete study capable give full write informed consent . EXCLUSION CRITERIA : Patients one follow exclude : 1 . Inability unwillingness undergo SPECT study procedures 2 . Pregnant lactate woman 3 . Atypical druginduced PD 4 . Current treatment dopamine agonist , MAO COMT inhibitor , anticholinergic 5 . Patients past ( within 1 year ) present history psychotic symptom require antipsychotic treatment . Patients may take antidepressant medication , however , dose must stable 4 week prior Baseline Visit . Use antipsychotic medication include clozapine quetiapine prohibit , even indication movement disorder . 6 . Current prior treatment ( within 4 week prior Baseline Visit ) pergolide , tolcapone , methyldopa , budipine , reserpine , seroquel , herbal dopamine agonist , Mucuna Pruriens 7 . Patients current prior treatment ( within 4 week prior Baseline Visit ) medication know induce enzyme cytochrome P450 3A4 8 . Use investigational product within 4 week prior randomization patient participate previous study perampanel 9 . Patients past present history drug alcohol abuse per Diagnostic Statistical Manual 4th edition ( DSM IV ) criteria 10 . Dementia ( define MMSE score ≤ 24 ) and/or fulfil criterion dementia due PD ( define Diagnostic Statistical Manual American Psychiatric Association 4th Edition ) 11 . Clinically significant unstable medical psychiatric illness 12 . Presence physical , mental , social condition precludes inform consent interferes careful followup 13 . Past ( within 1 year ) present history suicidal ideation suicide attempt 14 . Elevations liver enzymes , alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) ≥ 1.5 time upper limit normal ( ULN ) 15 . Patients unstable abnormality hepatic , renal , cardiovascular , respiratory , gastrointestinal , haematological , endocrine , metabolic system might complicate assessment tolerability study medication 16 . Evidence significant active hematological disease : white blood cell ( WBC ) count ≤ 2500/μL ; absolute neutrophil count ≤ 1000/μL 17 . Patients previous stereotactic surgery ( eg , pallidotomy ) Parkinson 's disease plan stereotactic surgery study period 18 . Patients receive plan receive ( within 3 month ) deep brain stimulation 19 . Patients condition affect peripheral central sensory system unless related Parkinson 's disease ( mild sensory pain syndromes limit `` OFF '' period ) could interfere evaluation symptom cause study drug 20 . Patients condition would make patient , opinion investigator , unsuitable study 21 . Patients clinically significant ECG abnormality , include prolonged QTc ( define QTc &gt; 450 msec )</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>